More on our ongoing collaboration with W. David Merryman, Walters Family Professor of Biomedical Engineering at VU, on addressing pulmonary arterial hypertension (PAH) using peripherally restricted 5-HT2B antagonists. Discoveries in Medicine - Antagonist of Serotonin 2B Blunts Heart and PAH Remodeling (vanderbilthealth.com)
Discoveries in Medicine - Vanderbilt Health Update
Previous
Previous
CAS Life Sciences Advisory Board
Next
Next